Validation of Active Compound of Terminalia catappa L. Extract and Its Anti-Inflammatory and Antioxidant Properties by Regulating Mitochondrial Dysfunction and Cellular Signaling Pathways
Journal of Microbiology and Biotechnology · 28.10.2024 · 34 (10) · 2118-2131
DOI: 10.4014/jmb.2407.07044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, online erschienen am 02.09.2024. Verfasst von So Jeong Paik und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Republic of Korea. Hauptthemen laut MEDLINE: Terminalia, Anti-Inflammatory Agents, Plant Extracts, Antioxidants. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea, Ministry of Education, Korea Institute of Marine Science and Technology promotion.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Republic of Korea.
- National Institute of Horticultural and Herbal Science, Rural Development Administration, Wanju 553635, Republic of Korea.
- Institute of Ecology and Biological Resources, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Cau Giay, Ha Noi, Vietnam.
- International Biological Material Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon 34141, Republic of Korea.
- Department of Microbiology, College of Medicine, Dankook University, Cheonan 31116, Republic of Korea.
- Multidrug-resistant Refractory Cancer Convergence Research Center (MRCRC), Dankook University, Cheonan 31116, Republic of Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Education
- Korea Institute of Marine Science and Technology promotion
- Ministry of Oceans and Fisheries
- Korea Research Institute of Bioscience and Biotechnology
- đTđL.CN-72/22
Zitieren
APA
Paik, S. J., Kim, D. S., Son, J. E., Bach, T. T., Hai, D. V., Paik, J. H., Jo, S., Kim, D. J., & Jung, S. K. (2024). Validation of Active Compound of Terminalia catappa L. Extract and Its Anti-Inflammatory and Antioxidant Properties by Regulating Mitochondrial Dysfunction and Cellular Signaling Pathways. Journal of Microbiology and Biotechnology, 34(10), 2118-2131. https://doi.org/10.4014/jmb.2407.07044
Vancouver
Paik SJ, Kim DS, Son JE, Bach TT, Hai DV, Paik JH, et al. Validation of Active Compound of Terminalia catappa L. Extract and Its Anti-Inflammatory and Antioxidant Properties by Regulating Mitochondrial Dysfunction and Cellular Signaling Pathways. Journal of Microbiology and Biotechnology. 2024;34(10):2118-2131. doi:10.4014/jmb.2407.07044
BibTeX
@article{Paik2024,
author = {Paik, So Jeong and Kim, Dong-Shin and Son, Joe Eun and Bach, Tran The and Hai, Do Van and Paik, Jin-Hyub and Jo, Sangjin and Kim, Dong Joon and Jung, Sung Keun},
title = {Validation of Active Compound of Terminalia catappa L. Extract and Its Anti-Inflammatory and Antioxidant Properties by Regulating Mitochondrial Dysfunction and Cellular Signaling Pathways},
journal = {Journal of Microbiology and Biotechnology},
year = {2024},
volume = {34},
number = {10},
pages = {2118--2131},
doi = {10.4014/jmb.2407.07044}
}
EUVIMED